We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





Bioperfectus Showcases Its Molecular Diagnostic Products for Infectious Diseases at MEDLAB 2022 Online

By LabMedica International staff writers
Posted on 25 Jan 2022
Print article
Image: STC-96A Real-Time PCR System (Photo courtesy of Bioperfectus)
Image: STC-96A Real-Time PCR System (Photo courtesy of Bioperfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) presented its molecular diagnostic products for various infectious diseases at MEDLAB 2022 Online from January 5 to February 28, 2022.

Bioperfectus used its virtual booth to exhibit the STC-96A Real-Time PCR system and STC-96A Plus Real-Time PCR system that are more-than-ever flexible, efficient and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. The temperature uniformity of the STC-96A Plus and STC-96A Plus across 96 wells is within a remarkable 0.1℃, which meets all needs for highly precise diagnostic and study use, including High-Resolution Melting Curve (HRM) applications

Bioperfectus also highlighted its COVID-19 testing solutions, including the COVID-19 Coronavirus Real Time PCR Kit, an In Vitro Diagnostic (IVD) reagent using fluorescent PCR technology to qualitatively detect Open Reading Frame gene region (ORF1a/b) and viral nucleocapsid region (N) of SARS-CoV-2 RNA from upper and lower respiratory tract specimens. In addition, the company presented the Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit, including Prepacked Extraction Tube, which is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days of the onset of symptoms.

Visitors exploring its online booth also viewed the Nucleic Acid Extraction Solutions produced by Bioperfectus that offer a comprehensive PCR laboratory solution, including SSNP series Nucleic Acid Extraction System (3000A, 2000B & 9600A), Nucleic Acid Extraction Rapid Kit (Magnetic Bead Method) as well as Viral Nucleic Acid Isolation Kit (Silica-Based Spin Column), which integrates new technologies such as machine, electricity and computer software to enable automatic nucleic acid extraction in one time.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.